Clinical Trials
21 trialsNCT06616571 2024-09-27
Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
Qilu Pharmaceutical Co., Ltd.
Phase 4 Recruiting
NCT03433560 2024-05-14
An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)
Kyowa Kirin Co., Ltd.
Completed
NCT03104595 2023-08-15
Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
Enzychem Lifesciences Corporation
Phase 1/2 Completed
NCT05061654 2023-08-14
CEF-10
Hamad Medical Corporation
Phase 4 Withdrawn
NCT04466137 2022-02-09
Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy
Xiamen Amoytop Biotech Co., Ltd.
Phase 3 Completed
NCT04662892 2020-12-23
POEM
Coherus Oncology, Inc.
Unknown
NCT04460079 2020-07-07
Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN
Cinnagen
Completed
NCT02544685 2019-01-17
FENSY
S&D Pharma SK s.r.o.
Phase 2 Unknown
NCT02005458 2018-07-17
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Xiamen Amoytop Biotech Co., Ltd.
Phase 2 Completed
NCT01619423 2018-07-06
PLIANT
Egetis Therapeutics
Phase 1/2 Completed
NCT00911170 2017-12-29
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Amgen
Phase 3 Completed
NCT02732327 2017-07-21
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Forest Laboratories
Phase 2 Terminated
NCT01569087 2016-12-05
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
Biocad
Phase 2 Completed
NCT02104830 2016-10-24
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
Biocad
Phase 3 Completed
NCT01459653 2016-01-11
Monitor-GCSF
Sandoz
Completed
NCT02119715 2014-04-22
A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT01706562 2013-02-20
A Study of Empirical Antifungal Therapy With Itraconazole
Janssen Korea, Ltd., Korea
Completed
NCT01611051 2013-01-08
A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Completed
NCT01560195 2012-11-06
A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT00035425 2009-12-01
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
Pfizer
Phase 3 Completed
NCT00454272 2009-03-06
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
Sanofi
Phase 4 Completed